Level B· Emerging clinical evidence with positive signalsRandomized Controlled TrialEurope PMCOpen access

Randomized Controlled Trials for Platelet-Rich Plasma Use in Knee Osteoarthritis Rarely Report Key Sociodemographic Patient Variables: A Scoping Review

Kotlier JL., Fathi A., Feingold CL., Lin EH., Yang A., Payton D.

Randomized Controlled Trial on Knee Osteoarthritis, Osteoarthritis, published in Arthrosc Sports Med Rehabil (2024) — summary generated from the PubMed abstract.

Open my reading list
Level B· Emerging clinical evidence with positive signalsEvidence level of this study

Several human studies show positive signals, while research methods and sample sizes continue to develop.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Randomized Controlled Trial
Journal
Arthrosc Sports Med Rehabil (2024)
Reported sample size
—
Source database
Europe PMC
PMID
39776510
PMCID
PMC11702004
DOI
10.1016/j.asmr.2024.100988

Abstract (original English)

Purpose To investigate the characteristics and rate of sociodemographic variables reported in randomized controlled trials (RCTs) studying platelet-rich plasma (PRP) injections in the treatment of knee osteoarthritis (OA). Methods In January 2024, PubMed, Scopus, and Web of Science databases were queried for the phrase "Platelet-Rich Plasma Knee Osteoarthritis." Included studies were RCTs investigating PRP use in knee OA published in English between 2012 and 2023. Each RCT was inspected for patient age and sex or gender as well as the following sociodemographic variables: race, ethnicity, insurance status, income, housing status, work status, and education. Data were presented in a descriptive fashion and analyzed using χ 2 test and Fisher's exact test to compare 2 and 3 categorical variables, respectively, with significance defined as P Results From 2012 through 2023, 71 RCTs met inclusion criteria. Included publications reported both age and sex or gender in 71/71 papers (100%). Reporting rates for other sociodemographic variables were as follows: race (3/71, 4.23%), work status (5/71, 7.04%), and education (3/71, 4.23%). No studies included the ethnicity, insurance status, income, or housing status of the enrolled patients. There was no difference in reporting sociodemographic variables by journal ( P = .083) or by year of publication ( P = .340). Sociodemographic variables

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Several human studies show positive signals, while research methods and sample sizes continue to develop.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research